Using digital health, analytics, and evidence networks to change how we understand neurology

Hope is increasing for patients affected by multiple sclerosis (MS), Parkinson's Disease, stroke, Alzheimer’s Disease, and other neurological disorders. But getting those advances to the right patients requires more than hope. Advanced analytics and machine learning that give your clinical team deeper insights into patient medicine use and outcomes. And market and sales analytics that enable your commercial team to target messaging, measure brand performance, and maximize sales force effectiveness. IQVIA works with disease registries and other neurology information providers to create powerful neurology specific evidence platforms and networks.

  • Leverage leading real-world data in ten neurology indications, including multiple sclerosis, Alzheimer’s, Parkinson’s Disease, epilepsy, stroke and pain.
  • Access our digitized MRI and EMR data via our leading MS Network. Learn about our collaborations to create linked, integrated data sets for novel research.
  • Scale insight generation across your organization and across diagnoses with evidence platforms in multiple sclerosis, Alzheimer’s Disease and other neurology indications.

 IQVIA has helped develop or commercialize 100% of 2016’s top 20 neurology products.

Utilize our broad and deep neurology expertise to help you reduce costs, accelerate timelines and manage risk.

Harness IQVIA's Full Power

Introducing the IQVIA CORE™, the new way we'll innovate.

Central Nervous System
Take on the unique challenge of drug development in Central Nervous System diseases.
Learn more about Human Data Science in our latest issue of AccessPoint, The Rise of Human Data Science in the Real World